Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Aug 6, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how radiation therapy, a common treatment for cervical cancer, might change certain proteins and molecules in the cancer tissue over time. By understanding these changes, researchers hope to learn more about how cervical cancer behaves and how the treatment affects the body. Women who are already planned to receive radiation therapy as part of their usual care will be asked to give blood samples and small tissue samples from the cervix or nearby areas before treatment starts, during treatment, and on the last day of radiation.
To take part, women need to be 18 years or older, have a confirmed diagnosis of cervical cancer, and be scheduled to receive a specific type of radiation called brachytherapy. Pregnant or breastfeeding women, or those who cannot provide tissue samples, cannot join. Participants can expect to provide these samples during their regular treatment visits, which helps doctors study the effects of radiation without extra procedures. This study is currently looking for volunteers who meet these criteria.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Pathological diagnosis of cervical cancer
- • Scheduled to receive brachytherapy for cervical cancer
- Exclusion Criteria:
- • Pregnancy or lactation
- • Inability to provide a tissue sample
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Trial Officials
Jyoti Mayadev, MD
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported